Phthalates are a class of synthetic chemicals used to make rigid plastics flexible and durable, and they are found in an enormous range of everyday products, including food packaging, medical devices, vinyl flooring, and children’s toys. Over the past two decades, a growing body of epidemiological and laboratory evidence has linked phthalate exposure to an increased risk of premature birth, infertility, and other health concerns, prompting manufacturers to seek alternatives. DINCH emerged as one of the most prominent of these substitutes and has been marketed as a plasticizer with a more favorable safety profile. The new study suggests, however, that the assumption of safety may deserve closer scrutiny, because higher maternal DINCH levels were consistently associated with reduced newborn size, a marker that clinicians consider an important early indicator of lifelong health risk.

The scale of the association was quantified precisely by the research team. Every tenfold increase in exposure to DINCH corresponded to a 27-gram reduction in newborn birth weight. While 27 grams may appear modest in isolation, the researchers emphasize that even small differences in birth size can matter significantly at the population level. Fetal growth problems can raise the risk of heart disease, learning difficulties, obesity, and other conditions that echo into adolescence and adulthood, a phenomenon known as the developmental origins of health and disease. Lead author Leonardo Trasande, MD, MPP, the Jim G. Hendrick, MD, Professor of Pediatrics at NYU Grossman School of Medicine, noted that a chemical promoted as a safer replacement for phthalates and other plasticizers may affect how babies grow in the womb, and that even small shifts in birth size can carry consequences across the life course.

The study drew its data from the Environmental Influences on Child Health Outcomes program, a National Institutes of Health initiative that tracks families’ health from pregnancy through childhood. One of the strengths of this cohort is its diversity: participants came from many different racial, ethnic, and economic backgrounds across the United States, making the results more representative of the nation than those of many earlier studies, which often relied on smaller or more homogeneous samples. Urine samples were analyzed for three DINCH breakdown products, the metabolites that the body produces as it processes and excretes the chemical. Some participants provided more than one sample, which allowed the researchers to track exposure across different trimesters of pregnancy, a methodological advance that distinguishes this work from prior analyses.

Indeed, the researchers report that this is the first study to measure DINCH at different times during pregnancy, and the timing of exposure proved to be an important variable. DINCH exposure during the third trimester was more strongly tied to lower birth weight for gestational age than exposure earlier in pregnancy, a pattern that aligns with the biology of late gestation, when fetal growth accelerates rapidly and nutrient and oxygen transfer through the placenta becomes especially critical. The analysis also accounted for other factors known to influence birth size, including the mother’s age, education, and number of previous pregnancies, strengthening the case that the observed associations are not simply artifacts of confounding.

The results revealed notable patterns beyond overall weight. Babies whose mothers had higher levels of DINCH in their urine were more likely to be classified as small for gestational age, a clinical designation applied when a newborn’s weight falls below the 10th percentile for babies born at the same stage of pregnancy. Sex-specific differences emerged as well: boys showed greater differences in birth length, while girls were more likely to be small for their gestational age. Between 50 percent and 70 percent of the pregnant women in the study had measurable levels of a DINCH by-product in their urine, indicating that exposure to this substitute plasticizer is widespread in the American population rather than confined to a narrow subset of consumers.

Mechanistically, laboratory studies in animals and human cells offer clues about how DINCH might influence fetal development. These studies suggest that when DINCH breaks down in the body, its by-products can interfere with hormones that guide fetal development and trigger inflammation that may affect how nutrients and oxygen reach the baby. Together, these effects may contribute to pregnancy complications such as reduced fetal growth, high blood pressure during pregnancy, and early labor. A small analysis of pregnant women undergoing fertility treatment has also linked higher DINCH exposure to an increased chance of preterm birth, although that particular finding was not observed in the current report, leaving the question of preterm delivery open for further investigation.

The study also raised concerns about disparities in exposure and health impacts. Mothers who were Hispanic or who had lower levels of education were more likely to have children affected by DINCH, according to the authors, a pattern consistent with broader evidence that chemical exposures are not evenly distributed across the population and that communities already facing structural disadvantages may bear a disproportionate share of environmental health burdens. Trasande argued that these results underscore the need for stronger oversight of chemicals used in food packaging and other household products, requiring that they be tested before they are introduced to the market rather than after they are connected to health concerns. He pointed to the global plastics treaty now under negotiation at the United Nations as a key opportunity to establish such policies.

The researchers were careful to note an important limitation: the analysis is observational and cannot prove that DINCH exposure directly causes smaller birth size. Observational studies of this kind identify associations within large populations, and while the team controlled for many known determinants of birth size, residual confounding remains a possibility in any study of environmental exposures. Nonetheless, the convergence of human epidemiological data with laboratory evidence of endocrine interference and inflammatory effects strengthens the biological plausibility of the findings and adds DINCH to the growing list of plastic additives whose health profiles warrant reexamination.

Looking ahead, the study authors plan to examine other plasticizers currently being used as alternatives to phthalates and to study in more detail how DINCH may slow fetal growth. Senior author Taylor Etzel, PhD, of Johns Hopkins University led the work alongside Trasande, with contributions from researchers at NYU Langone, RTI International, Northeastern University, Rutgers University, Johns Hopkins, the University of Colorado Anschutz, Emory University, Columbia University, the University of Michigan, Penn State University, the University of California, San Francisco, Dartmouth College, Wayne State University, the University of Washington, the University of Illinois at Urbana Champaign, and the University of North Carolina at Chapel Hill. Funding was provided by the National Institutes of Health’s Environmental Influences on Child Health Outcomes program. In the meantime, Trasande suggested that families concerned about plastic additives can talk with their healthcare providers and consider practical steps that may reduce exposure, while the scientific and policy communities continue to evaluate whether the replacements for yesterday’s problem chemicals are solving the problem or simply relocating it.

Subject of Research: Effects of prenatal exposure to the plasticizer DINCH on fetal growth and birth outcomes

Article Title: Exposure to ‘safer’ plastic additive during pregnancy linked to smaller birth size

Article References: Exposure to ‘safer’ plastic additive during pregnancy linked to smaller birth size. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: DINCH, phthalates, plasticizers, prenatal exposure, birth weight, fetal growth, endocrine disruption, ECHO program, Environment International, NYU Langone, plastics treaty, environmental health

The significance of the listing is explained in a recent paper led by Stanford University researchers and published in Frontiers in Environmental Science, which traces a decade of California’s evolving approach to microplastic regulation and draws lessons for other states and countries. The work, supported by the Stanford Center for Human and Planetary Health, was coauthored by environmental scientist Amelia Meyer, pediatric otolaryngologist Kara Meister, and policy specialist Sarina Patel, alongside Desiree LaBeaud of the Stanford School of Medicine and Chloe Smith of the London School of Economics Sustainability Regulation Observatory. Together, the authors argue that California’s incremental, multi-pronged strategy offers a working model at a moment when global governance of plastics has stalled.

According to Patel, a policy program manager at the Stanford Woods Institute for the Environment and a former California Legislature science fellow, the October 1 change matters because it resolves a long-standing legal ambiguity. While microplastics have been measured in the environment for years, there has been no coherent legal framework for treating them as pollution that must be mitigated. Classing microplastics as a chemical of concern, she explains, opens an important legal door. The listing itself does not restrict any product; it is the procedural prerequisite that allows the state to designate specific products for regulation, a process that still requires public comment and formal review before any rule takes effect.

The technical challenge facing regulators today is far greater than the one California confronted in 2015, when it banned microbeads in wash-off cosmetics such as facial scrubs. That law was relatively straightforward to design and enforce, Meyer notes, because microbeads were intentionally manufactured, had a clear point source, shared a common shape and texture, and were largely non-essential. Particles shed from tire wear and synthetic clothing present a fundamentally different regulatory problem. When microplastics are released continuously from millions of cars and washing machines, interventions cannot be confined to the manufacturing stage; they must reach into how products are used, maintained, and disposed of across the entire economy.

The scientific backdrop to these policy choices is sobering but incomplete. Microplastics have been detected in human blood, organs, and other bodily fluids, and some published studies and ongoing research projects have linked their presence to significantly higher rates of heart attack, stroke, and death. Yet detection is not causation: finding microplastics in the body does not prove they are responsible for that harm. Meyer emphasizes that uncertainty is a reason to continue research and reduce unnecessary exposure at the source, not a reason to wait until every question has been answered. This precautionary posture, she suggests, is precisely what the Candidate Chemicals List mechanism is designed to accommodate, allowing regulatory attention to begin before the full dose-response picture is resolved.

Meister, whose laboratory at the Stanford School of Medicine has documented microplastics in children’s tonsil tissue and is developing new methods to measure the body’s microplastic burden, raises a further concern about what travels with the particles. She describes microplastics as Trojan horses, noting that potentially thousands of other chemicals and polymers may be conjugated to them, including plasticizers such as bisphenol A, whose health effects are well documented. The reach, scope, and impact of these combined exposures, she argues, are only beginning to be understood, adding a layer of toxicological complexity that pure particle-counting studies do not capture.

California’s regulatory arc over the past decade shows a deliberate escalation. Since the 2015 microbead ban, the state has created a statewide microplastics strategy, established drinking-water standards for the particles, and passed SB 54, a law that assigns producers responsibility for the full life cycle of their products rather than just their creation. The legislation includes plans for a five-billion-dollar mitigation fund financed by manufacturer fees, which Meister describes as a public-facing, tangible step to raise awareness and mitigate the impacts of plastics in the state. Patel characterizes the cumulative effect as a toolkit: by taking a variety of regulatory approaches, California equips itself to tackle microplastic pollution across the scope of the problem, from production to waste management to environmental cleanup.

The urgency of state-level action is sharpened by the paralysis at the international level. Despite years of effort, United Nations negotiators have failed to agree on a binding plastics treaty, largely because of a deadlock over production caps. In that vacuum, states and other governmental bodies are charting their own course. Patel acknowledges the political headwinds, noting that strident voices supporting the plastics industry push back against regulation in the name of affordability. Her counterargument is economic as much as environmental: systemic change does cost money, but the damage plastic has done to the environment, to wildlife, and potentially to human health also carries a cost, and at present there is no accountability for those costs.

Meister warns that resistance is structural, because plastics are rooted in the petroleum industry, and that strong pushback to regulation is inevitable. That reality, she argues, makes a concentrated, cohesive effort willing to accept incremental progress essential. Without it, regulators risk what she calls regrettable substitutions, a hazard illustrated by the history of bisphenol A. After the U.S. Food and Drug Administration and some states restricted BPA, once widely used in food and drink packaging, manufacturers replaced it with alternative chemicals that studies indicate pose similar health dangers. The lesson for microplastic policy is that piecemeal, poorly coordinated rules can simply shift harm from one substance to another rather than reduce it.

For jurisdictions watching from afar, the Stanford authors contend that California’s experiment demonstrates what stronger regulation can look like in practice. The state is testing policies, generating evidence, and building the administrative machinery needed to govern a pollutant that is diffuse, persistent, and chemically entangled with the modern economy. As global treaty talks resume against a backdrop of scientific uncertainty and industrial resistance, the California model suggests that meaningful progress does not require waiting for perfect data or perfect international consensus. It requires, instead, a sequence of deliberate legal footholds, each one converting scientific observation into enforceable obligation, one listing at a time.

Subject of Research: California's regulatory approach to microplastic pollution and its implications for plastic policy

Article Title: Microplastics and the law explained: What California's new rule means for plastic policy

Article References: Microplastics and the law explained: What California's new rule means for plastic policy. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: microplastics, California, plastic pollution, Candidate Chemicals List, SB 54, regulation, Stanford University, plastics treaty, human health, environmental policy, toxicology, Frontiers in Environmental Science